Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2017 16:30 ET | Source: Depomed, Inc.

Depomed Announces NUCYNTA® Commercialization Agreement with Collegium Pharmaceutical

- Transaction is Immediately Accretive and Improves 2018 EBITDA Outlook - - Consistent with Stated Strategy of Maintaining a Strong NUCYNTA Franchise while Focusing on Neurology and Specialty...
November 21, 2017 16:05 ET | Source: Depomed, Inc.

Depomed to Participate at the Annual Piper Jaffray Healthcare Conference

NEWARK, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that senior management will participate in a fireside chat at the 29th Annual Piper Jaffray Healthcare...
November 07, 2017 16:05 ET | Source: Depomed, Inc.

Depomed Announces Third Quarter 2017 Financial Results

- Third Quarter Net Sales of $95 Million- - Slán Medicinal Holdings Transaction Creates New Specialty Unit and Diversifies Business - - Updates Full-Year Guidance - - Conference Call...
November 07, 2017 16:00 ET | Source: Depomed, Inc.

Depomed and Slán Medicinal Holdings Ltd Announce Strategic Asset Transactions

-Depomed to Acquire Cosyntropin Depot from Slán Medicinal Holdings Limited Creating New Specialty Pharmaceutical Business - - Slán Medicinal Holdings Limited to Acquire Lazanda® from Depomed - ...
October 31, 2017 16:03 ET | Source: Depomed, Inc.

Depomed to Report Third Quarter 2017 Financial Results on Tuesday, November 7, 2017

NEWARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release third quarter fiscal year 2017 financial results on Tuesday, November 7, 2017,...
October 18, 2017 08:00 ET | Source: Depomed, Inc.

Depomed Announces Appointment of Santosh J. Vetticaden, M.D., PH.D. as Senior Vice President, Chief Medical and Scientific Officer

NEWARK, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that Santosh J. Vetticaden, M.D., Ph.D., has joined Depomed as Senior Vice President, Chief Medical and...
October 10, 2017 07:30 ET | Source: Depomed, Inc

Depomed Provides Product Supply Information Following Hurricane Maria

NEWARK, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today provided information on the impact of Hurricane Maria to the supply of NUCYNTA® ER, which is manufactured in...
September 05, 2017 16:01 ET | Source: Depomed, Inc

Depomed to Present at the Morgan Stanley Global Healthcare Conference

NEWARK, Calif. , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that its senior management will participate in a fireside chat at the 2017 Morgan Stanley Global...
August 28, 2017 08:00 ET | Source: Depomed, Inc

Depomed to Join the Collaborative for Effective Prescription Opioid Policies to Advance Strategies Aimed at Addressing the Abuse of Opioids

NEWARK, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Depomed Inc. (NASDAQ:DEPO) today announced that it has been selected to join the Collaborative for Effective Prescription Opioid Policies (CEPOP) a...
August 07, 2017 16:01 ET | Source: Depomed, Inc

Depomed Announces Second Quarter 2017 Financial Results

- Updates Full-Year Financial Guidance - - Second Quarter Revenues of $100 million - - Increases Neurology Salesforce Effective September 1 - - Conference Call Scheduled for Today at 4:30 PM EDT;...